A revolutionary at-home 12-lead ECG service with 24/7 cardiologist review and telehealth service now fully available in the US. TEL AVIV, Israel & ZURICH, & NEW YORK / May 16, 2024 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL " or the " Company "), a leading provider and developer of advanced personal telemedicine solutions, is thrilled to announce that it recently officially launched it’s... Read More

TEL AVIV, Israel & ZURICH & NEW YORK / Apr 17, 2024 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, announced today its results for the full-year 2023, highlighting fiscally responsible growth across all regions and a strategic focus on expansion and innovation. In 2023, SHL Telemedicine... Read More

Groundbreaking Study reveals a 76% drop in hospital readmissions and a 41% decrease in Emergency Department visits, underscoring SHL and SmartHeart®’s pivotal role in remote cardiac care TEL AVIV & ZURICH & NEW YORK / Apr 11, 2024 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL " or the " Company "),... Read More

SHL’s SmartHeart portable 12-lead ECG technology successfully participated in the U.S. Army’s Project Convergence – Capstone 4 experiment (PC-C4), demonstrating exceptional reliability, user-friendliness, and effectiveness, even in extreme scenarios. TEL AVIV, Israel & ZURICH & NEW YORK / Apr 08, 2024 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL " or the " Company "), a leading provider and... Read More

TEL AVIV, Israel & ZURICH & NEW YORK / Apr 05, 2024 / Business Wire / SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN; NASDAQ: SHLT) (" SHL ” or the “ Company ”), a leading provider and developer of advanced personal telemedicine solutions, today announced that it will publish its results for 2023 on Wednesday, April 17, 2024 at 7 am CET. The conference call for investors, journalists, and analysts to discuss the annual... Read More

The selection of the TELE-ACS trial results for presentation at ACC 24 highlights the pioneering achievements of Imperial College London and SHL in advancing the field of telemedicine TEL AVIV, Israel & ZURICH & NEW YORK / Feb 01, 2024 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is excited to... Read More

SHL Telemedicine German Operation and BARMER, one of the top health insurance funds in Germany, to present at leading Germany Healthcare Conference TEL AVIV, Israel & ZURICH & NEW YORK / Dec 19, 2023 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL " or the " Company "), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce its participation as a... Read More

A revolutionary at-home 12-lead ECG service with 24/7 cardiologist review and telehealth service. TEL AVIV & ZURICH & NEW YORK / Nov 27, 2023 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL ” or the “ Company ”), a leading provider and developer of advanced personal telemedicine solutions is pleased... Read More

Pioneering a New Era of Cardiac Care, SHL Telemedicine Established a Comprehensive Network to Broaden Access to Expert Cardiology Services for B2B and Direct-to-Consumer Segments through its SmartHeart® Technology. TEL AVIV, Israel & ZURICH & NEW YORK / Nov 06, 2023 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL ” or the “ Company ”), a leading provider and developer of advanced personal... Read More

Making Significant Investments in Infrastructure and Technology, SHL Telemedicine Advances its US Direct-to-Consumer Strategy Post Positive Initial Trial Results TEL AVIV, Israel & ZURICH & NEW YORK / Oct 23, 2023 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL ” or the “ Company ”), a leading provider and developer of advanced personal telemedicine solutions is pleased to announce that it has made... Read More

Promising outcomes indicate significant reductions in emergency visits and hospital readmissions, alongside reductions in healthcare utilization costs relating to post-MI patient treatment TEL AVIV, Israel & ZURICH & NEW YORK / Sep 26, 2023 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL ” or the “ Company ”), a leading provider and developer of advanced personal telemedicine solutions, is pleased... Read More

TEL AVIV, Israel & ZURICH & NEW YORK / Sep 21, 2023 / Business Wire / Regulatory News: SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) (“ SHL ” or the “ Company ”), a leading provider and developer of advanced personal telemedicine solutions, announced today its results for half-year 2023, emphasizing stable revenues and strategic growth initiatives. In H1 2023, SHL maintained stable revenues while making... Read More

Initial results from the Mayo Clinic HELP-MI and the Imperial College London TELE-ACS trials to be presented at the Vulnerable Plaque and Patient Meeting (VPM) 2023. TEL AVIV, Israel & ZURICH & NEW YORK / Sep 11, 2023 / Business Wire / SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (" SHL ” or the “ Company ”), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce that... Read More

TEL AVIV, Israel , ZURICH and NEW YORK , Sept. 6, 2023 /PRNewswire/ -- SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (NASDAQ: SHLT) (" SHL " or the " Company "), a leading provider and developer of advanced personal telemedicine solutions, today announced that it will issue its Half-year 2023 results before market opens on Thursday, September 21, 2023 . The conference call for investors, journalists, and analysts to... Read More